CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm3 Versus Universal Eligibility for Antiretroviral Therapy | Zendy

Alan Schooley | Zendy; Pocha Samuel Kamudumuli | Zendy; Sitaram Vangala | Zendy; ChiHong Tseng | Zendy; Chifundo Soko | Zendy; Julie Parent | Zendy; Khumbo Phiri | Zendy; Andreas Jahn | Zendy; Dan Namarika | Zendy; Risa M. Hoffman | Zendy

Open Access

CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm3 Versus Universal Eligibility for Antiretroviral Therapy

Author(s) -

Alan Schooley,

Pocha Samuel Kamudumuli,

Sitaram Vangala,

ChiHong Tseng,

Chifundo Soko,

Julie Parent,

Khumbo Phiri,

Andreas Jahn,

Dan Namarika,

Risa M. Hoffman

Publication year - 2016

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofw180

Subject(s) - interquartile range , medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , antiretroviral treatment , demography , covid-19 , viral load , statistics , immunology , mathematics , disease , sociology , infectious disease (medical specialty)

Our data show low accuracy of a single CD4 count for individuals with observed CD4 counts of 350-650 cells/mm3. We hope our data will be interesting to programs making decisions around continued use of CD4 thresholds versus adopting WHO universal eligibility for ART.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research